Paper40413660
The role and diagnostic value of deregulated miRNAs in cervical cancer.
Parvizi M and 7 others. Discov Oncol, 2025. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. The role and diagnostic value of deregulated miRNAs in cervical cancer. Papers, record 40413660. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40413660
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 67334 | Tabriz University of Medical Sciences | PubMed |
Source PubMed
References187
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30161290 | miR-381-3p restrains cervical cancer progression by downregulating FGF7. | J Cell Biochem | 2019 | https://conductscience.org/library/papers/30161290 | PubMed |
| 2 | 32410650 | Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma. | BMC Cancer | 2020 | https://conductscience.org/library/papers/32410650 | PubMed |
| 3 | 24793973 | MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A. | Gynecol Oncol | 2014 | https://conductscience.org/library/papers/24793973 | PubMed |
| 4 | 30314496 | MiR-218 produces anti-tumor effects on cervical cancer cells in vitro. | World J Surg Oncol | 2018 | https://conductscience.org/library/papers/30314496 | PubMed |
| 5 | 32356483 | Diagnostic Values of miR-21, miR-124, and M-CSF in Patients With Early Cervical Cancer. | Technol Cancer Res Treat | 2020 | https://conductscience.org/library/papers/32356483 | PubMed |
| 6 | 26878391 | MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression. | Oncogenesis | 2016 | https://conductscience.org/library/papers/26878391 | PubMed |
| 7 | 29531222 | miR-27a inhibits cervical adenocarcinoma progression by downregulating the TGF-βRI signaling pathway. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/29531222 | PubMed |
| 8 | 32945424 | MicroRNA‑130a‑3p promotes the proliferation and inhibits the apoptosis of cervical cancer cells via negative regulation of RUNX3. | Mol Med Rep | 2020 | https://conductscience.org/library/papers/32945424 | PubMed |
| 9 | 30260270 | Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer. | Cancer Biol Ther | 2018 | https://conductscience.org/library/papers/30260270 | PubMed |
| 10 | 33990639 | Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer. | Sci Rep | 2021 | https://conductscience.org/library/papers/33990639 | PubMed |
| 11 | 35747791 | Emerging Role of MicroRNAs in the Therapeutic Response in Cervical Cancer: A Systematic Review. | Front Oncol | 2022 | https://conductscience.org/library/papers/35747791 | PubMed |
| 12 | 29945565 | MicroRNAs as markers of progression in cervical cancer: a systematic review. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29945565 | PubMed |
| 13 | 36908850 | miR-19-3p Targets PTEN to Regulate Cervical Cancer Cell Proliferation, Invasion, and Autophagy. | Genet Res (Camb) | 2023 | https://conductscience.org/library/papers/36908850 | PubMed |
| 14 | 33327867 | A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer. | Technol Cancer Res Treat | 2020 | https://conductscience.org/library/papers/33327867 | PubMed |
| 15 | 33906322 | Pap Smear miR-92a-5p and miR-155-5p as potential diagnostic biomarkers of squamous intraepithelial cervical cancer. | Asian Pac J Cancer Prev | 2021 | https://conductscience.org/library/papers/33906322 | PubMed |
| 16 | 33112434 | Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis. | APMIS | 2021 | https://conductscience.org/library/papers/33112434 | PubMed |
| 17 | 28928798 | Regulatory roles of miRNA-758 and matrix extracellular phosphoglycoprotein in cervical cancer. | Exp Ther Med | 2017 | https://conductscience.org/library/papers/28928798 | PubMed |
| 18 | 29333098 | MiR-22-3p Regulates Cell Proliferation and Inhibits Cell Apoptosis through Targeting the eIF4EBP3 Gene in Human Cervical Squamous Carcinoma Cells. | Int J Med Sci | 2018 | https://conductscience.org/library/papers/29333098 | PubMed |
| 19 | 11402272 | Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | 2001 | https://conductscience.org/library/papers/11402272 | PubMed |
| 20 | 31815762 | Overexpression of microRNA-21 decreased the sensitivity of advanced cervical cancer to chemoradiotherapy through SMAD7. | Anticancer Drugs | 2020 | https://conductscience.org/library/papers/31815762 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42652115 | Overcoming mTOR Inhibitor Resistance: From Biological Basis to Therapeutic Strategies. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652115 | PubMed |
| 42625954 | Unravelling the nexus of non-coding RNAs in cancer stemness and therapeutic drug resistance. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42625954 | PubMed |
| 42377617 | miR-4687-3p modulates cell proliferation and migration in cervical cancer cells. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42377617 | PubMed |
| 42121949 | Circulating microRNA Profiles as Diagnostic Tools for High-Grade Cervical Lesions and HPV Genotype Stratification. | Cells | 2026 | https://conductscience.org/library/papers/42121949 | PubMed |
| 41723567 | Identification of miRNA biomarkers and development of predictive signatures for early detection and prognosis in cervical precancer and cancer. | Hum Genomics | 2026 | https://conductscience.org/library/papers/41723567 | PubMed |
| 41464230 | Integrating Biomarkers into Cervical Cancer Screening-Advances in Diagnosis and Risk Prediction: A Narrative Review. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/41464230 | PubMed |
| 41413752 | The clinical significance of circulating microRNAs as biomarkers in lung cancer diagnosis and prognosis. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41413752 | PubMed |
| 41331059 | Exploring shared microRNA profiles in liquid-based cytology and plasma as biomarkers of high-grade intraepithelial lesions. | Sci Rep | 2025 | https://conductscience.org/library/papers/41331059 | PubMed |
| 41272778 | Circulating potential biomarkers in polycystic ovary syndrome and gynecologic cancers: Diagnostic insights from a systematic review and meta-analysis. | J Ovarian Res | 2025 | https://conductscience.org/library/papers/41272778 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MIR1908 | 100302263 | PubTator's text mining | https://conductscience.org/library/genes/100302263 | NCBI Gene |
| MIR21 | 406991 | PubTator's text mining | https://conductscience.org/library/genes/406991 | NCBI Gene |
| MIR4262 | 100422996 | PubTator's text mining | https://conductscience.org/library/genes/100422996 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40413660
GET https://conductscience.org/api/papers/v1/40413660/references?page=2